Objective-To determine cardiorespiratory effects of a tiletamine/zolazepam-
ketamine-detomidine (TZKD) combination in horses.
Animals-8 healthy adult horses.
Procedure-Horses were instrumented far measurement of cardiorespiratory, ac
id-base, and electrolyte values. Each horse was given xylazine (0.44 mg/kg
of body weight, IV) 10 to 15 minutes prior to induction of recumbency by ad
ministration of the TZKD combination. Cardiorespiratory, acid-base, and ele
ctrolyte values were measured at 5-minute intervals for greater than or equ
al to 30 minutes.
Results-All horses became recumbent within 1 minute after IV administration
of TZKD. Mean +/- SD duration of recumbency was 40 +/- 8 minutes. All hors
es regained standing position after less than or equal to 2 attempts. Quali
ty of anesthesia and analgesia was determined to be satisfactory in all hor
ses. Xylazine induced decreases in respiratory rate, heart rate, cardiac ou
tput, maximum rate of increase of right ventricular pressure, and rate pres
sure product. The PaCO2 right atrial pressure, and peripheral vascular resi
stance increased, whereas blood temperature, PO2, pHa, HCO3- PCV, total sol
ids, Na, and K values remained unchanged. Subsequent administration of TZKD
caused right atrial pressure and PaCO2 to increase and PaO2 to decrease, c
ompared with values obtained after xylazine administration. Remaining cardi
orespiratory, acid-base, hematologic, and electrolyte values did not differ
from those obtained after xylazine administration.
Conclusion-IV administration of TZKD induces short-term anesthesia in horse
s. Potential advantages of this drug combination are the small volume of dr
ug administered; minimal cardiorespiratory depression; quality of induction
and maintenance of, and recovery from, anesthesia; and duration of drug ef
fects.